See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2018_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001430306')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,443,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 91,000 |
| 3 | remainder_Assets | 100,000 |
| 4 | LiabilitiesCurrent | 2,126,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 12,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,949,000 |
| 9 | ResearchAndDevelopmentExpense | 13,342,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 168,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 26,754,000 |
| 1 | Liabilities | 2,138,000 |
| 2 | Expenses | 21,291,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 24,616,000 |
| 5 | NetIncome | -21,123,000 |
| 6 | ComprehensiveNetIncome | -21,125,500 |
| 7 | BaseVar | 25,178,000 |
| 8 | EconomicCapitalRatio | 1.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
